Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron Gives Partners Proteomics Center Four New LC/MS Systems

NEW YORK, Oct. 18-Thermo Electron and Partners HealthCare will officially announce an instrumentation research partnership at a symposium today celebrating Partners' new proteomics center.


The high-tech equipment company has donated four Thermo Finnegan ProteomeX liquid chromatography mass spectrometry systems to the proteomics wing of the Harvard-Partners Center for Genetics and Genomics. A Thermo proteomics application specialist will also be in residence at the new center to provide support for the systems and provide feedback to the company.


"It seemed like a good opportunity for both of us," said Thermo Electron spokesperson Caroline Grossman. "He will be a support to them in terms of helping them figure out the best ways to run the experiments they want to. From our point of view, we're always looking to develop tools that researchers really want to use."


The new genomics center will also serve as a showcase for the ProteomeX machines, said Grossman. These systems, which Thermo launched last March, retail for about $300,000.


Researchers throughout the Partners system, which includes Harvard Medical School, Brigham and Women's Hospital and Massachusetts General Hospital, can use the machines for clinical proteomics research.


Proteomics researchers John Yates of the Scripps Research Institute and Donald Hunt of the University of Virginia are scheduled to speak at the Partners symposium today, which will be held at the Massachusetts Institute of Technology.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.